What question did this study set out to answer?

This research examines the efficacy and tolerability of two treatments for hyperkalemia.

March 14, 2026Open Access

Efficacy and Tolerability of Sodium Zirconium Cyclosilicate or Patiromer in Managing Hyperkalemia

Puntos clave

This research examines the efficacy and tolerability of two treatments for hyperkalemia.
Comparison of Sodium Zirconium Cyclosilicate and Patiromer in patients with hyperkalemia.
Assessment of serum potassium levels and safety considerations for both treatments.
Both treatments effectively lower serum potassium levels.
Distinct safety considerations were observed for each therapy.

Resumen

Both SZC and patiromer effectively lower serum potassium and provide clinical benefits, with distinct safety considerations. Therapy selection should be guided by treatment goals and the patient's individual risk profile.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Wathanavasin et al. (Wed,) studied this question.

synapsesocial.com/papers/69b4b9eb18185d8a39802191 https://doi.org/https://doi.org/10.34067/kid.0000001173

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo